Exelon
E494102
Exelon is a brand-name prescription medication containing rivastigmine, used to treat symptoms of mild to moderate dementia associated with Alzheimer's and Parkinson's disease.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Exelon canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T5114880 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Exelon Context triple: [rivastigmine, hasBrandName, Exelon]
-
A.
Exelon
Exelon is a major American energy company and utility services holding corporation, known for operating one of the largest fleets of nuclear power plants in the United States.
-
B.
Xcel Energy
Xcel Energy is a major U.S. electric and natural gas utility company serving millions of customers across several Midwestern and Western states.
-
C.
Constellation Energy
Constellation Energy is a U.S.-based energy company that generates and supplies electricity, with a significant focus on nuclear power and other low-carbon energy sources.
-
D.
Cinergy Corporation
Cinergy Corporation was a U.S.-based energy company best known in part for its naming rights sponsorship of Cincinnati’s Cinergy Field baseball stadium.
-
E.
Reliant Energy
Reliant Energy is a U.S.-based retail electricity provider and energy company known for supplying power to residential and commercial customers, particularly in Texas.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Exelon Target entity description: Exelon is a brand-name prescription medication containing rivastigmine, used to treat symptoms of mild to moderate dementia associated with Alzheimer's and Parkinson's disease.
-
A.
Exelon
Exelon is a major American energy company and utility services holding corporation, known for operating one of the largest fleets of nuclear power plants in the United States.
-
B.
Xcel Energy
Xcel Energy is a major U.S. electric and natural gas utility company serving millions of customers across several Midwestern and Western states.
-
C.
Constellation Energy
Constellation Energy is a U.S.-based energy company that generates and supplies electricity, with a significant focus on nuclear power and other low-carbon energy sources.
-
D.
Cinergy Corporation
Cinergy Corporation was a U.S.-based energy company best known in part for its naming rights sponsorship of Cincinnati’s Cinergy Field baseball stadium.
-
E.
Reliant Energy
Reliant Energy is a U.S.-based retail electricity provider and energy company known for supplying power to residential and commercial customers, particularly in Texas.
- F. None of above. chosen
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
brand-name prescription medication
ⓘ
cholinesterase inhibitor ⓘ rivastigmine-containing medicine ⓘ |
| affects | acetylcholine levels in the brain ⓘ |
| belongsToDrugClass |
acetylcholinesterase inhibitors
ⓘ
cholinesterase inhibitors ⓘ |
| commonSideEffect |
diarrhea
ⓘ
dizziness ⓘ loss of appetite ⓘ nausea ⓘ tremor ⓘ vomiting ⓘ weight loss ⓘ |
| contraindication |
known hypersensitivity to rivastigmine
ⓘ
previous severe skin reaction to rivastigmine patch ⓘ |
| dosageForm |
oral capsule
ⓘ
oral solution ⓘ transdermal patch ⓘ |
| effect |
may improve activities of daily living in dementia
ⓘ
may improve or stabilize cognitive function ⓘ |
| hasActiveIngredient | rivastigmine ⓘ |
| indicatedPopulation |
adults with mild to moderate Alzheimer’s dementia
ⓘ
adults with mild to moderate Parkinson’s disease dementia ⓘ |
| mayCause |
bradycardia
ⓘ
syncope ⓘ |
| mechanismOfAction |
inhibits butyrylcholinesterase
ⓘ
reversibly inhibits acetylcholinesterase ⓘ |
| metabolism | primarily via cholinesterase-mediated hydrolysis ⓘ |
| notIndicatedFor |
severe Alzheimer’s dementia
ⓘ
treatment of behavioral symptoms alone without dementia diagnosis ⓘ |
| regimen | requires gradual dose titration to minimize side effects ⓘ |
| regulatoryStatus | prescription-only medicine ⓘ |
| requires | prescription ⓘ |
| routeOfAdministration |
oral
ⓘ
transdermal ⓘ |
| therapyType | symptomatic treatment of dementia ⓘ |
| treats |
mild dementia associated with Alzheimer’s disease
ⓘ
mild dementia associated with Parkinson’s disease ⓘ moderate dementia associated with Alzheimer’s disease ⓘ moderate dementia associated with Parkinson’s disease ⓘ |
| usedFor |
treatment of cognitive symptoms
ⓘ
treatment of memory impairment ⓘ treatment of reasoning problems ⓘ treatment of thinking problems ⓘ |
| warning |
use with caution in patients with active peptic ulcer disease
ⓘ
use with caution in patients with asthma or obstructive pulmonary disease ⓘ use with caution in patients with cardiac conduction disorders ⓘ use with caution in patients with urinary obstruction ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Exelon Description of subject: Exelon is a brand-name prescription medication containing rivastigmine, used to treat symptoms of mild to moderate dementia associated with Alzheimer's and Parkinson's disease.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.